Condensed Consolidated Statements Of Comprehensive Income/(Loss) (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||||
|---|---|---|---|---|---|---|
Dec. 31, 2017 |
Dec. 31, 2016 |
Dec. 31, 2017 |
Dec. 31, 2016 |
|||
| Revenue: | ||||||
| Total revenue | $ 0 | $ 0 | $ 0 | $ 0 | ||
| Operating expenses | ||||||
| Research and development | 355,300 | 267,638 | 713,585 | 794,433 | ||
| General and administrative | 121,053 | 107,728 | 627,605 | 397,598 | ||
| Total operating expenses | 476,353 | 375,366 | 1,341,190 | 1,192,031 | ||
| Loss from operations | (476,353) | (375,366) | (1,341,190) | (1,192,031) | ||
| Interest income | 9,988 | 0 | 74,006 | |||
| Net loss | (466,365) | (375,366) | (1,267,184) | (1,192,031) | ||
| Other comprehensive income (loss): | ||||||
| Foreign Currency Transaction Adjustment | 36,641 | (396,445) | 398,705 | (786,148) | ||
| Comprehensive loss | $ (429,724) | $ (771,811) | $ (868,479) | $ (1,978,179) | ||
| Loss per share | ||||||
| Basic and diluted | [1] | |||||
| Weighted Average Number of Shares Outstanding | 121,411,478 | 205,000,000 | 177,035,840 | 205,000,000 | ||
| ||||||